Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium chloride + sodium chloride is a combination electrolyte replacement therapy containing essential cations and anions for the maintenance of fluid and electrolyte balance. Available in both oral supplement and intravenous injection forms, it is primarily used to treat or prevent potassium and sodium deficiencies. The intravenous solution is indicated for parenteral fluid and electrolyte replenishment, while oral formulations are often used as dietary supplements to alleviate tiredness, muscle cramps, and heat prostration resulting from excessive perspiration. As small molecule electrolytes, these components are critical for normal nerve conduction, muscle contraction, heart rhythm, and renal function. The intravenous formulation is a sterile, nonpyrogenic solution providing potassium (K+) and sodium (Na+) ions, requiring careful monitoring to prevent electrolyte imbalances such as hyperkalemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + sodium chloride.